Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Bio Sciences has informed the BSE that its trading window for dealing in company securities will remain closed from January 1, 2026 until 48 hours after the announcement of its standalone unaudited financial results for the third quarter ending December 31, 2025. The closure is being done under SEBI's Insider Trading Regulations, 2015 and the company's own internal code of conduct for insiders. The restriction applies to all designated persons, their immediate relatives, and connected persons covered under the code. As per a SEBI circular dated July 19, 2023, the company will also freeze the PANs of designated persons and their immediate relatives during this window closure period. The date of the board meeting to declare the Q3 results has not yet been announced and will be communicated separately.
This is a routine regulatory compliance notice and not an event that should move the stock price on its own. However, it signals that the company's Q3 FY26 results are due soon, which retail investors may want to watch for as fresh fundamental information.